Radionuclide GRPR imaging in malignant pathology of the mammary and prostate glands: clinical experience
In this lecture, we presented current clinical studies on targeted radionuclide imaging of breast and prostate tumors with overexpression of the gastrin-releasing peptide receptor (GRPR). The gastrin-releasing peptide receptor is a transmembrane receptor, the activation of which promotes the growth...
Saved in:
| Main Authors: | O. D. Bragina, A. G. Ivanova, E. A. Usynin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2025-04-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/5975 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells
by: Tyrillshall S.T. Damiana, et al.
Published: (2025-08-01) -
A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression
by: Esther Olaniran Håkansson, et al.
Published: (2025-08-01) -
USE OF <sup>177</sup>Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
by: A. A. Medvedeva, et al.
Published: (2021-06-01) -
Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
by: O. D. Bragina, et al.
Published: (2021-04-01) -
Comparative Analysis of the Clinical Use of 99mTechnetium-Labeled Recombinant Target Molecules in Different Dosages for the Radionuclide Diagnosis of Her2-Positive Breast Cancer
by: O. D. Bragina, et al.
Published: (2021-06-01)